Autoimmune Diseases  >>  rontalizumab (RG7415)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rontalizumab (RG7415) / Roche
NCT00962832: A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

Checkmark P2 data
Jun 2015 - Jun 2015: P2 data
Checkmark Systemic Lupus Erythematosus - ACR/ARHP 2013 (ROSE)
Sep 2013 - Sep 2013: Systemic Lupus Erythematosus - ACR/ARHP 2013 (ROSE)
Checkmark EULAR 2013
More
Completed
2
238
US, Europe, RoW
Placebo, Rontalizumab
Genentech, Inc.
Systemic Lupus Erythematosus
01/12
08/13

Download Options